This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Life Technologies Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Senthilvelan Annamalai: Innovator in RNA Cap Analog Technology
Introduction
Senthilvelan Annamalai is a notable inventor based in Austin, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of RNA cap analogs. His work has implications for both research and therapeutic applications.
Latest Patents
Annamalai holds a patent titled "Trinucleotide cap analogs, preparation and uses thereof." This patent generally relates to trinucleotide RNA cap analogs, methods of use thereof, and kits comprising the same. The trinucleotide cap analogs provided in this patent allow for the ready detection and/or isolation of capped RNA transcripts in vitro and facilitate the translation of capped mRNAs in vivo. He has 1 patent to his name.
Career Highlights
Annamalai is currently employed at Life Technologies Corporation, where he continues to advance his research in RNA technologies. His work is pivotal in enhancing the understanding and manipulation of RNA molecules, which are crucial for various biological processes.
Collaborations
Some of his notable coworkers include Tyson Vonderfecht and Shanmugasundaram Muthian. Their collaborative efforts contribute to the innovative environment at Life Technologies Corporation.
Conclusion
Senthilvelan Annamalai is a prominent figure in the field of RNA research, with a focus on trinucleotide cap analogs. His contributions are shaping the future of biotechnology and molecular biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
